|Project Title||Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis|
This analysis investigates the risk of non-melanoma skin cancer for patients treated with hydrochlorothiazide-containing products compared to non-hydroclorothiazide angiotensin-converting-enzyme inhibitor (ACEI)-containing products, including captopril, enalapril maleate, and lisinopril monotherapies and combination therapies in the Sentinel Distributed Database. The Level 2 analytic package for this analysis is now publicly available in the Sentinel Git repository.
Tuesday, June 11, 2019
- Vaccines, Blood & Biologics
- Devices and Radiologic Health